• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

124
16
12
10
9

COUNTRY

4
4
3
3
2

PRICE

91
121
262
449

PUBLISHED

39
49
109
449

PRODUCT TYPE

442
6
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Pemphigus Global Clinical Trials Review, H2, 2014

Pemphigus Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Pemphigus Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus clinical trial scenario. This...

October 2014
FROM

Type I hypersensitivity Global Clinical Trials Review, H2, 2014

Type I hypersensitivity Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Type I hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Type I hypersensitivity...

October 2014
FROM

Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014

Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014" provides data on the Wegener’s...

October 2014
FROM

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Rheumatoid Arthritis...

October 2014
FROM

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the...

October 2014
FROM

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014" provides data...

October 2014
FROM

Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014

Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus Vulgaris clinical...

October 2014
FROM

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Wiskott-Aldrich...

October 2014
FROM

Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014

Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Von...

October 2014
FROM

Graves Diseases Global Clinical Trials Review, H2, 2014

Graves Diseases Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Graves Diseases Global Clinical Trials Review, H2, 2014" provides data on the Graves Diseases clinical trial...

October 2014
FROM

Mild Psoriasis Global Clinical Trials Review, H2, 2014

Mild Psoriasis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Mild Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Mild Psoriasis clinical trial...

October 2014
FROM

Peanut Allergy Global Clinical Trials Review, H2, 2014

Peanut Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Peanut Allergy Global Clinical Trials Review, H2, 2014" provides data on the Peanut Allergy clinical trial...

October 2014
FROM

Moderate Psoriasis Global Clinical Trials Review, H2, 2014

Moderate Psoriasis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Moderate Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Moderate Psoriasis clinical...

October 2014
FROM

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014" provides...

October 2014
FROM

Ragweed Allergy Global Clinical Trials Review, H2, 2014

Ragweed Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Ragweed Allergy Global Clinical Trials Review, H2, 2014" provides data on the Ragweed Allergy clinical trial...

October 2014
FROM

Pollen Allergy Global Clinical Trials Review, H2, 2014

Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Pollen Allergy clinical trial...

October 2014
FROM

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014" provides data on the X-Linked...

October 2014
FROM

Severe Psoriasis Global Clinical Trials Review, H2, 2014

Severe Psoriasis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Severe Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Severe Psoriasis clinical...

October 2014
FROM

Spondylitis Global Clinical Trials Review, H2, 2014

Spondylitis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Spondylitis Global Clinical Trials Review, H2, 2014" provides data on the Spondylitis clinical trial scenario....

October 2014
FROM
Disease & Therapy Review (DTR) Executive Market Summaries Disease & Therapy Review (DTR) Executive Market Summaries - Product Thumbnail Image

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

November 2014
Loading Indicator

Our Clients

Our clients' logos